Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (22)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Progress in Wound-Healing Products Based on Natural Compounds, Stem Cells, and MicroRNA-Based Biopolymers in the European, USA, and Asian Markets: Opportunities, Barriers, and Regulatory Issues

    Polymers, Vol. 16, Núm. 9

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study

    Environmental Research, Vol. 229

2022

  1. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21

2020

  1. Environmental factors are associated with hospital admissions for sepsis-related pneumonia: A bidirectional case-crossover design

    Environmental Research, Vol. 191

  2. VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension

    European Journal of Internal Medicine, Vol. 80, pp. 60-65

2019

  1. Brimonidine-induced unilateral ocular lichen planus: A case report

    Arquivos Brasileiros de Oftalmologia

  2. National temporal trend analysis of infective endocarditis among patients infected with HIV in Spain (1997–2014): A retrospective study

    Journal of Clinical Medicine, Vol. 8, Núm. 8

  3. Role of corneal nerves in ocular surface homeostasis and disease

    Acta Ophthalmologica, Vol. 97, Núm. 2, pp. 137-145

  4. Transforming growth factor beta-induced p.(L558P) variant is associated with autosomal dominant lattice corneal dystrophy type IV in a large cohort of Spanish patients

    Clinical and Experimental Ophthalmology, Vol. 47, Núm. 7, pp. 871-880

  5. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia

    Atherosclerosis, Vol. 285, pp. 17-22

2018

  1. Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulation

    Experimental Eye Research, Vol. 167, pp. 118-121

2017

  1. Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells

    Experimental Eye Research, Vol. 154, pp. 79-87

2014

  1. Purinergic receptors in ocular inflammation

    Mediators of Inflammation, Vol. 2014

2011

  1. Activation of MAPK signaling pathway and NF-κB activation in pterygium and ipsilateral pterygium-free conjunctival specimens

    Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 8, pp. 5842-5852

2009

  1. Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone

    Experimental Eye Research, Vol. 89, Núm. 2, pp. 238-245

2006

  1. Cataractous Changes due to Posterior Chamber Flattening with a Posterior Chamber Phakic Intraocular Lens Secondary to the Administration of Pilocarpine

    Ophthalmology, Vol. 113, Núm. 8, pp. 1283-1288